JPRN-UMIN000011828已完成未知
Efficacy and safety of combination therapy of vildagliptin and insulin - Combination therapy of vildagliptin and insulin
Department of Internal Medicine, School of Medicine, Keio University0 个研究点目标入组 40 人开始时间: 2013年9月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Type 1 diabetes mellitus 2. Ketosis, DM coma or precoma 3. Severe infection, before or after operation, severe trauma 4. Severe liver dysfunction 5. Patients who have allergy to the medicine used in this study 6. preganant or possible pregnant women
研究者
相似试验
已完成
不适用
Efficacy and safety of combination therapy with vildagliptin and nateglinide in type 2 diabetes.JPRN-UMIN000004010Department of Medicine, Metabolism and Endocrinology, Juntendo University Graduate School of Medicine40
已完成
不适用
The efficacy and safety of combination therapy of adoptive immunotherapy with chemotherapy for advanced pancreatic cancerJPRN-UMIN000011177Tokai University School of Medicine20
尚未招募
不适用
IDA for OnchocerciasisOnchocerciasisPACTR201906665550709Washington University in St. Louis300
招募中
不适用
Efficacy and safety of combination therapy with tolvaptan and dapagliflozin in patients with acute decompensated heart failure: A randomized controled trialAcute decompensated heart failureJPRN-UMIN000039340Kansai Medical University30
进行中（未招募）
1 期
Safety and efficacy of combination treatment with rituximab and leflunomide in patients with active rheumatoid arthritis - Rituximab and Leflunomide in RAEUCTR2005-004582-41-GBniversity of Leeds15